China’s Role in Addressing the Ebola Crisis in East Africa

China’s Potential in Combating Ebola

As Ebola continues to spread in East Africa, the United States plays a substantially smaller role than in previous outbreaks. This shift presents an opportunity for China, known for its economic strength and expertise in epidemic control and biotechnology, to step up.

In Mongbwalu, located in the Democratic Republic of Congo, which is the epicenter of the outbreak, treatment centers face severe shortages of equipment, medicine, and essential supplies. The Bundibugyo virus, responsible for the outbreak, complicates containment efforts due to the absence of an approved vaccine or treatment. The lack of testing further impedes efforts to control its spread.

The Extent of China’s Involvement

Despite China’s significant investments in the region, its willingness to aggressively confront what may become the deadliest Ebola outbreak remains uncertain. With reduced U.S. intervention compared to pre-Trump era emergency responses, China encounters less competitive pressure to take action. Beijing’s cautious approach may result in delayed involvement in addressing the outbreak in this remote, conflict-affected region.

“Now we are in this moment of truth,” said Bradley Parks, executive director of AidData, a research lab at William & Mary.

For China, this crisis poses a critical question: will it leave a leadership void or rise to the occasion?

This week, China took an initial step towards involvement, nearly three weeks after the outbreak was reported. It dispatched a team of five medical experts to Kinshasa, Congo’s capital, over 1,000 miles from the outbreak’s center.